The world of natural compounds has been investigated with the aim of discovering possible medical applications ever since the origin of medicine. Recently, the field of gynecology has developed a growing interest regarding inositols. Inositols are cyclic polyols with a key role in many metabolic pathways. Their stability throughout the evolution of life can mark these molecules as prebiotic, due to their biochemical importance. These molecules can be classified into nine stereoisomeric compounds; among them, myo-inositol (MI) is the most important and frequent form found in nature. Inositols were first discovered in 1850 by Johanes Joseph Scherer and extracted from muscle cells, the name of which still persist in the compound (myo¼muscle in greek). In humans, inositols are derived from the diet in the primary form of MI. Subsequently, MI can be unidirectionally converted into different forms such as D-chiro-inositol (DCI), thanks to insulin action, and with the action of a specific nicotinamide adenine dinucleotide (NAD)-NADH-dependent epimerase. The primary focus of this chapter is to examine and discuss the biochemical properties of DCI and its clinical implication. In particular, it will provide the details of possible clinical applications of DCI supplementation in women, considering the principal biochemical effects.

Laganà AS, A.C. (2023). Supplementation with D-chiro-inositol in women. In A clinical guide to Inositols (pp. 179-195). Academic Press (Elsevier) [10.1016/B978-0-323-91673-8.00004-2].

Supplementation with D-chiro-inositol in women

Laganà AS
Primo
;
2023-01-15

Abstract

The world of natural compounds has been investigated with the aim of discovering possible medical applications ever since the origin of medicine. Recently, the field of gynecology has developed a growing interest regarding inositols. Inositols are cyclic polyols with a key role in many metabolic pathways. Their stability throughout the evolution of life can mark these molecules as prebiotic, due to their biochemical importance. These molecules can be classified into nine stereoisomeric compounds; among them, myo-inositol (MI) is the most important and frequent form found in nature. Inositols were first discovered in 1850 by Johanes Joseph Scherer and extracted from muscle cells, the name of which still persist in the compound (myo¼muscle in greek). In humans, inositols are derived from the diet in the primary form of MI. Subsequently, MI can be unidirectionally converted into different forms such as D-chiro-inositol (DCI), thanks to insulin action, and with the action of a specific nicotinamide adenine dinucleotide (NAD)-NADH-dependent epimerase. The primary focus of this chapter is to examine and discuss the biochemical properties of DCI and its clinical implication. In particular, it will provide the details of possible clinical applications of DCI supplementation in women, considering the principal biochemical effects.
Settore MED/40 - Ginecologia E Ostetricia
https://www.elsevier.com/books/a-clinical-guide-to-inositols/unfer/978-0-323-91673-8
Laganà AS, A.C. (2023). Supplementation with D-chiro-inositol in women. In A clinical guide to Inositols (pp. 179-195). Academic Press (Elsevier) [10.1016/B978-0-323-91673-8.00004-2].
File in questo prodotto:
File Dimensione Formato  
23 - Supplementation with D-chiro-inositol in women.pdf

Solo gestori archvio

Descrizione: Full Text
Tipologia: Versione Editoriale
Dimensione 3.38 MB
Formato Adobe PDF
3.38 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/578409
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact